NDC 0032-0045-70

Creon 15000 [USP'U]/1

Pancrelipase · CAPSULE, DELAYED RELEASE

No Recall History

Creon is a capsule, delayed release containing pancrelipase at a strength of 15000 [USP'U]/1. Manufactured by AbbVie Inc..

Key Facts

Brand Name: Creon
Generic Name: Pancrelipase
NDC Code (Package): 0032-0045-70
NDC Code (Product): 0032-0045
Manufacturer: AbbVie Inc.
Strength: 15000 [USP'U]/1
Dosage Form: CAPSULE, DELAYED RELEASE
Route: ORAL
Marketing Status
Application #: BLA020725
Marketing Start: 10/12/2023

Recall History

No Recall History

View Full Drug Page

Creon — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.